Oura reportedly plans September IPO at over $16 billion valuation
This digest was compiled by AI from multiple sources — links to the originals are below.
Oura, the smart ring maker, is reportedly planning a U.S. IPO as soon as September that could value the company at more than $16 billion. The company aims to raise up to $3 billion, with investors expected to sell a major stake. The reported valuation marks a sharp jump from the $10.9 billion Oura was assigned last September.
Key Facts
- Oura is reportedly planning to raise up to $3 billion in a U.S. IPO as soon as September, according to Bloomberg.
- The reported IPO valuation of more than $16 billion compares with the $10.9 billion valuation Oura received in its $875 million Series E round last September.
- Oura announced in May that it had filed confidentially for an IPO.
- Oura generated $500 million in revenue in 2024 and roughly $1 billion in 2025, and expects close to $2 billion in 2026.
- A proposed class action lawsuit filed last week in San Francisco accuses Oura of misleading consumers about the accuracy of its sleep tracking features.
IPO Plans
Oura, with offices in San Francisco and Finland, is reportedly planning a U.S. IPO as soon as next month. The company aims to raise up to $3 billion, and investors are expected to sell a major chunk of stock in the offering. A $16 billion valuation would mark a sharp increase from the $10.9 billion valuation Oura received in its $875 million Series E round last September. Oura announced in May that it had filed confidentially for an IPO.
Market Position
The wearables space has grown crowded, with Samsung launching its Galaxy Ring two years ago. Whoop, Oura's most direct rival, reached a $10 billion valuation in March after expanding beyond elite athletes to a broader audience with hormone tracking and blood-panel testing. Oura has followed a similar path, evolving from a niche biohacking brand into a mainstream sleep-and-recovery company. Oura reported $500 million in revenue in 2024 and roughly $1 billion in 2025, and expects close to $2 billion in 2026.
Legal Challenge
A proposed class action lawsuit filed last week in San Francisco accuses Oura of misleading consumers about the accuracy of its sleep tracking features. The filing claims Oura asserts it can measure the exact stage of sleep, which in reality requires electrodes in the scalp and sensors on the eyes in a clinical setting. An Oura spokesperson said the company plans to defend against the claims and that its sleep staging has been validated in multiple studies against polysomnography.
2 sources
Oura reportedly plans September IPO at over $16 billion valuation
